您好,欢迎访问中国农业科学院 机构知识库!

Glutathione-responsive nanoplatforms trigger gaseous intervention of intestinal inflammation through TLR4/MD2/MyD88/NF-κB/iNOS pathway activation and gut microbiota modulation

文献类型: 外文期刊

作者: Li, Yanfei 1 ; Zhu, Beiwei 1 ; Chen, Tao 1 ; Chen, Lihang 1 ; Wu, Di 1 ; Wang, Xinchuang 1 ; Li, Dongmei 1 ; Li, Wei 2 ; Sun, Yinshi 3 ; Hu, Jiangning 1 ;

作者机构: 1.Dalian Polytech Univ, Natl Engn Res Ctr Seafood, Collaborat Innovat Ctr Seafood Deep Proc, Sch Food Sci & Technol,SKL Marine Food Proc & Safe, Dalian 116034, Peoples R China

2.Jilin Agr Univ, Sch Life Sci, Changchun 130118, Peoples R China

3.Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Changchun 130112, Peoples R China

关键词: Chronic intestinal inflammation; Diallyl trisulfide; Gaseous intervetion; Glutathione-responsive nanoplatforms; serum albumin; gut microbiota modulation

期刊名称:CHEMICAL ENGINEERING JOURNAL ( 影响因子:13.3; 五年影响因子:13.2 )

ISSN: 1385-8947

年卷期: 2024 年 493 卷

页码:

收录情况: SCI

摘要: Overproduction of reactive oxygen species (ROS) is a primary cause of chronic intestinal inflammation, controlled nanosequence-like drugs with GSH-responsive release have become a new focus in scavenging ROS and treating inflammation. Here, we report an endogenous GSH-responsive nanoplatform, meticulously engineered for the controlled release of hydrogen sulfide (H2S) within inflamed intestinal tissues, thus offering a new avenue for gaseous intervention against chronic enteritis. Diallyl trisulfide (DS) as molecular H2S donors was conjugated into sulfhydrylated bovine serum albumin (BSA & sdot;SH) through a 'thio-ene' click chemistry reaction, leading to the synthesis of the BSA@DS polymer. This substrate was subsequently coated with hyaluronic acid, yielding HA-BSA@DS nanoparticles. As sulfide bonds in DS are responsive to intracellular GSH to release H2S and HA achieves inflamed site-targeted release specifically towards CD44-overexpressed inflamed tissues, these nanoparticles attenuate pro-inflammatory cytokine outputs while concurrently upregulate anti-inflammatory factors, thus mitigating cellular oxidative perturbations and inflammatory responses in inflamed cells. Moreover, upon oral administration, these nanoparticles exhibit profound anti-inflammatory efficacy via the TLR4/ MD2/MyD88/NF-kappa B/iNOS signal pathway and modulating the homeostasis of intestinal microbiota in a mouse model with colitis. Consequently, this convenient and targeted oral nanoparticle effectively enables gaseous multiple intervention at the inflammatory site, providing a favorable theoretical basis for subsequent oral formulations in the treatment of related inflammation.

  • 相关文献
作者其他论文 更多>>